WGS
GeneDx Holdings Corp. · Healthcare · Medical - Diagnostics & Research
动量输入（同类管理人）：
持有人广度 -6.2% ·
股份流向 -4.5% ·
净新建仓位 -6.7%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 88 | -5 | 15.43M | $1.06B | +10 | −14 |
| Q1 2026 | 95 | +2 | 15.21M | $977.50M | +14 | −13 |
| Q4 2025 | 94 | +1 | 15.07M | $1.96B | +3 | −1 |
| Q3 2025 | 16 | -1 | 7.41M | $798.15M | +2 | −4 |
| Q2 2025 | 15 | -1 | 4.67M | $430.80M | +1 | −2 |
| Q1 2025 | 13 | 0 | 2.11M | $186.46M | — | — |
| Q4 2024 | 13 | +1 | 1.90M | $146.41M | +2 | −1 |
| Q3 2024 | 11 | +4 | 1.69M | $71.81M | +4 | — |
| Q2 2024 | 7 | — | 992.14K | $25.94M | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 1.43M | — | $132.43M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (被动) | 1.18M | — | $109.01M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Geode Capital Management ✦ (被动) | 484.71K | +23.4% | $44.75M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (被动) | 416.00K | +22.5% | $38.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 406.57K | -4.5% | $37.53M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 6 | Citadel Advisors ✦ | 272.23K | +858.7% | $25.13M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 163.32K | — | $15.08M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 122.75K | +332.9% | $11.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Norges Bank ✦ (被动) | 68.00K | 0.0% | $6.28M | 0.0% | Held | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 52.55K | -81.7% | $4.85M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 23.71K | -5.4% | $2.19M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 12 | T. Rowe Price ✦ | 15.05K | +36.7% | $1.39M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | Marshall Wace ✦ | 12.70K | 新增 | $1.17M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | D. E. Shaw & Co. ✦ | 9.15K | -97.7% | $845,098 | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 4.49K | -67.3% | $414,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $1.17M | 0.0% |
已清仓
| Renaissance Technologies | $6.22M | 曾为 0.0% |
| Millennium Management | $1.40M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 240 持有人, 31.22M 股份, $1.98B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 3.04K 股 · $300,846
Officer · 1.08K 股 · $106,816
Officer, Director · 1.65K 股 · $155,337
Officer, Director · 148 股 · $14,120
Officer, Director · 1.52K 股 · $147,774
Officer, Director · 4.14K 股 · $406,936
Officer · 586 股 · $55,235
Officer · 52 股 · $4,961
Officer · 541 股 · $52,423
Officer · 1.47K 股 · $144,457
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
1.8% 占股份类别 · 查看 SEC 原始申报文件 ↗